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Background: Surgery of thoracoabdominal aortic aneurysms (TAAA) is associated with high incidence of serious
complications. Ischemia/reperfusion (I/R) injury may be responsible for these complications. We investigated the
effect of degree of anticoagulation on remote organ I/R injuries and whether heparin is protective against I/R injury
in addition to its anticoagulant properties.
Methods: Spraque Dawley rats were used to determine both liver and kidney concentrations of HSP-70,IL-6, MPO
in four groups: ischemic control (operation with cross-clamping and intraperitoneal administration of 0.9% saline,
n = 7), sham (operation without cross-clamping, n = 7), heparin (ACT level about 200), and high dose heparin
(ACT level up to 600). Histological analyses of the organs were performed.
Results: Histopathological evaluation of kidney presented significant differences between groups with regards to
the cytoplasmic vacuole formation, hemorrhage, tubular cell degeneration and tubular dilatation while heparinized
group had best results. The kidney MPO and HSP-70 levels significantly decreased (p < 0.05), but IL-6 level was not
significant (p > 0.05) in heparinized group when compared to ischemic control group. No statistically significant
intergroup differences were detected in the tissue samples of liver. Immunohistochemical markers of the liver were
compared and no statistically significant difference was found among the groups.
Conclusion: Heparin is an important anticoagulation agent in TAAA surgical procedures but the use of higher
levels of heparin in the present study revealed no beneficial effects. Bleeding complications is much less when
heparin is used in the real-world clinical practice as ACT levels of 200.
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Surgical repair of thoracoabdominal aortic aneurysms
(TAAAs) are highly complex and challenging interven-
tions. It is not surprising that this operation is associated
with a high incidence of serious complications, often
leading to respiratory failure, renal failure, neurological
deficits or even death.
Multiorgan dysfunction, presumably related to activa-
tion of inflammatory pathways and over production of* Correspondence: yener@comu.edu.tr
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unless otherwise stated.cytokines and other inflammatory mediators, is a major
cause of death. The systemic inflammatory response syn-
drome (SIRS), ischemia-reperfusion injury (I/Ri), and in-
flammatory pathway activation are considered precursors
of morbidity and mortality after open TAAA repair [1-3].
Cytokines such as IL-6 are important mediators of the
inflammatory response in ischemia. Plasma IL-6 concen-
tration increased gradually, reached its peak 24 hours
after surgery, and correlated with aortic cross-clamp
time and morbidity. The observed correlation between
plasma IL-6 and aortic cross-clamp time supports the
hypothesis that the IL-6 response mainly reflects the im-
pact of ischemia and reperfusion rather than the impact
of surgical trauma in elective TAAA surgery. The strongtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ous reports suggesting that plasma IL-6 is a reliable pre-
dictor of outcome in elective TAAA repair [4-6].
Heat shock proteins (HSPs) are cellular stress proteins
which have been shown to have an important role for the
survival of cells under stress conditions [7]. Zhang et al. [8]
pointed out that, HSP70 could respond to a wide variety of
stress conditions such as ischemia, and inflammation. It
can prevent the irreversible denaturation of proteins [9].
Elevated expression of HSP70 can prevent cell death pro-
cesses [10]. It has been showed that overexpression of
HSP70 attenuate the release of inflammatory factors and
interferes with the process of apoptotic cell death [10-12].
Myeloperoxidase (MPO) is one of the obvious indicators
for the tissue infiltration of neutrophilic granulocytes. MPO
activity increases in response to the I/R injury [13].
Heparin continues to dominate anticoagulation ther-
apy for surgical repair of TAAA and other cardiovascular
surgical procedures. Heparin is best recognized for its
ability to prevent blood coagulation by catalytically accel-
erating the interaction of antithrombin III (AT III) with
thrombin, as well as with factors XIIa, IXa, Vlla, and Xa,
thereby inhibiting the proteases necessary for completion
of the coagulation cascade [14].
Beside heparin is known to possess effects independent
of its anticoagulant activity, it plays a role in inhibition of
leukocyte-mediated damage [15,16]. Other important and
often unrecognized actions of heparin and other glycosami-
noglycans are their ability to inhibit complement activation
[17] and to exhibit anti-inflammatory effects [18-20].
In this study, we investigated the effect of the degree of
anticoagulation on remote organ I/R injury and whether
heparin is protective against I/R injury beside its anti-
coagulant properties.
Methods
Animal and surgical procedure
This study was approved by the Animal Experiment
Committee of Düzce University Graduate School of
Medicine and all animal care and use were in accord-
ance with the European Convention for Animal Care. 28
male Sprague–Dawley rats weighing 250 to 350 g were
used for the experiment. Rats were fed standard labora-
tory diets and were maintained in a temperature- and
photoperiod-controlled (12 hr/day) room. The rats were
followed for 15 days before the procedure. None of the
animals had any abnormality before operation.
Study groups
The animals were randomly divided into four groups
(7 rats each). 1) Sham-operation group. The operation
was performed in the same form, but without aortic oc-
clusion and heparin administration. 2) Non- heparinized
control group rats’ abdominal aortas were clamped for45 minutes. 3) Low-dose heparin treated group animals’
aortas were cross-clamped for 45 minutes and 400 IU/kg
of heparin was administered. ACT was kept around 200
during the procedure. 4) High-dose heparin treated group.
In this group rats’ aortas was cross-clamped for 45 minutes
and 800 IU/kg of heparin was administered. ACT was
kept around 600 during the procedure.
Operative procedure and technique
Premedication was intraperitoneally applied with ketamine
(50 mg/kg) and xylazine (5 mg/kg) to rats. Anesthesia
was continued by intermittent injections of ketamine,
without endotracheal intubation and mechanical ven-
tilation. Temperature probe was placed in the rectum.
Rats were placed in supine position. After sterile prep-
aration of the surgical area, a standard midline laparot-
omy incision was made, and after the intestines were
retracted the abdominal aorta was explored transperito-
neally.The abdominal aorta at the below renal arteries
and above the iliac bifurcation levels was cross-clamped
during surgical procedures. The duration of the ischemic
insult was 45 minutes. Temperature was maintained be-
tween 36.5 and 37.5°C during the procedure. Following re-
moval of the aortic clamps, abdominal wall was repaired by
using 5/0 polyprolene suture. Penthobarbital (20 mmg/kg)
was used as anesthetic at the 48th hour and all the animals
were sacrificed. The liver and kidney was dissected totally
and fixed in buffered formalin for 7 days.
Histopahological assessment
The liver and kidney were removed and fixed in 10% for-
malin for histopathologic examination. About 4 μm thick
paraffin sections were cut and collected on glass slides.
5 μm thick sections were located on polylysine-coated slides
and were stained with hematoxylin and eosin (H & E). The
glass slides were examined by light microscopy (Olympus
BX51; Olympus Corp. Tokyo, Japan) at 400× magnification.
Immunohistochemical assessment
Blood samples were obtained directly from the cardiac
of groups of four rats at the end of 48 h immediately be-
fore the sacrification. Blood samples were obtained with
sterile 10 ml syringe after the chest wall was cleansed
with cholorohexidine in spirit. Blood samples for cyto-
kine assay were collected into heparinized (20 unit/ml
blood) sterile tubes and immediately transferred on ice
to be centrifuged at 2000 rpm (at 4°C) for 10 minutes
and stored (−70°C) until the time of assay for IL-6, MPO
and HSP-70. These marker levels were obtained from
blood samples together with kidney and liver tissue.
Analysis of HSP
4 μm thick paraffin sections were prepared. Deparaffini-
zation and hydration of tissue sections was performed in
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with primary anti-HSP70 (clone BRM.22, dilution 1/80,
Biogenex, San Ramon, California) diluted in buffer. Nega-
tive control was PBS.
Analysis of IL-6
Immunohistochemical detection of IL-6 receptor was
performed with polyclonal anti-human IL-6 receptor
antibody C-20 (Santa Cruz Biotechnologies, Santa Cruz,
CA, USA). The antibody was diluted 1: 20. Streptavidin-
biotin-peroxidase protocol was applied in IL-6 receptor
immunostaining. The secondary anti-rabbit antibody was
diluted 1: 500. After the first antibody was omitted nega-
tive controls were conducted.
Analysis of MPO
Immuno-histochemical evaluation of MPO activities of
the liver and kidney tissues was performed with an anti-
MPO kit according to the manufacturer’s protocol. Depar-
affinization and hydration of samples on polylysine-coated
slides was performed. Then, the microwave antigen re-
trieval procedure was performed, and the samples were
incubated in a 3% H2O2 solution to inhibit endogenous
peroxidase. The sections were incubated with a blocking
solution for blocking nonspecific background staining.
Then incubation of the sections with primary anti-MPO
antibody and with biotinylated goat anti-mouse antibody
followed. After incubation with chromogenic substrate
(DAB), the sections were counterstained with hematoxylin
and eosin (H & E). The slides were examined under a light
microscope and two pathologists who did all analyses
were blinded to group assignments. The staining of cyto-
plasmic MPO in the neutrophils was evaluated, and the
results were expressed as the percentage of neutrophils cy-
toplasmically stained positive for MPO. Tissues with no
evidence of staining, or only rare scattered positive cells,
less than 3%, were recorded as negative. The immunohis-
tochemical results were evaluated for intensity and fre-
quency of staining. The intensity of staining was graded as
0 (negative), 1 (weak), 2 (moderate), and 3 (strong). The
frequency was graded from 0 to 4 by the percentage of
positive cells as follows: grade 0, <3%; grade 1, 3-25%;
grade 2, 25-50%; grade 3, 50-75%; grade 4, more than 75%.
The index score was the product of multiplication of the
intensity and frequency grades, which was then classified
into a 4 point scale: index score 0 = product of 0, index
score 1 = products 1 and 2, index score 2 = products 3
and 4, index score 3 = products 6 through 12.
Statistical analysis
Statistical analysis and calculations were performed with
SPSS 15 for Windows (Chicago, IL). Results were expressed
as the mean (standard error mean). Intergroup differences
are detected by Kruskal-Wallis analysis of variance andMann–Whitney U test was used for statistical compari-
sons. While p value of < .01 was accepted as statistically
significant p value of < .05 was accepted as statistically less
significant.
Results
There was no significant difference with regards to body
temperature, mean arterial blood pressure and heart rate
among the groups.
Histopathological evaluation of the tissue samples
taken from the kidney showed significant intergroup differ-
ences in terms of the cytoplasmic vacuole formation,
hemorrhage, tubular cell degeneration and tubular dilata-
tion (P = 0.031, P = 0.003, P = 0.007, P = 0.011 respectively).
There was no cytoplasmic vacuole formation in the
kidney specimens of high dose-heparinized group, while
cytoplasmic vacuole formation was evident in the other
animals’ kidney; as shown in Table 1.
As depicted in Table 2, heparinized group of the examin-
ation compared with other groups showed no hemorrhage
according to histopathologic evaluation. Hemorrhage was
worst in the ischemic control group followed by sham and
high dose-heparinized group. Hemorrhage in the kidney
specimens of high dose-heparinized group may be due to
high levels of ACT (Table 1).
Examination of the kidney tissue revealed that ische-
mic control group showed most tubular cell degener-
ation according to histopathologic evaluation (P = 0.007);
whereas there was no degeneration in the high dose-
heparinized group.
There was no tubular dilatation in the kidney specimens
of sham and heparinized groups while tubular dilatation
was worst in the ischemic control group (P = 0.011).
Immunohistochemical markers as, MPO, HSP-70 and
IL-6 parameters were studied from the kidney tissue
samples. While there was no intergroup difference with
regards to IL-6 stain (p = 0.205), there were statistical
significant differences among the groups with regards to
MPO and HSP-70 stains (p value 0.01 and 0.004, re-
spectively) (Table 2). Grade 1, 2 and 3 staining with
MPO was strongest in the ischemic control group and
high dose-heparinized group whereas there was no stain-
ing in the heparinized group (P = 0.01). The lowest HSP-
70 level was measured in the sham group, after heparin-
ized groups while the highest HSP-70 level was measured
in the high dose-heparinized and ischemic control group.
IL6 staining results are given in Table 2. There was no sig-
nificant difference found among the groups (P = 0.205).
Histopathological evaluation of the tissue samples taken
from the liver showed no statistically significant inter-
group differences in terms of the hepatocyte degeneration,
hepatocyte steatosis, single cell necrosis, inflammatory
cell, sinusoidal dilatation and periportal bridging necrosis
(P = 0.587, P = 0.277, and P = 0.196 respectively) (Table 3).
Table 1 Histopathologic results of the kidney tissue
H&E Grade Ischemic control Sham Heparinized High dose-heparinized P values
Number % Number % Number % Number %
Cytoplasmic vacuole formation 0 0 0 1 20 4 66.7 3 100 0.031
1 3 100 4 80 2 33.3 0 0
Hemorrhage 0 0 0 3 60 6 100 2 66.7 0.003
1 3 100 2 40 0 0 1 33.3
Tubular cell degeneration 0 0 0 4 80 5 83.3 3 100 0.007
1 3 100 1 20 1 16.7 0 0
Tubular dilatation 0 0 0 5 100 6 100 1 33.3 0.011
1 1 33.3 0 0 0 0 2 66.7
2 2 66.7 0 0 0 0 0 0
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ischemia- reperfusion injury of the liver tissue in an aortic
occlusion model of rats revealed that there was no statisti-
cally significant difference found among the groups in
terms of MPO, HSP70 and IL-6 (P = 0.152, P = 0.053, and
P = 0.243 respectively) (Table 4).
Discussion
Despite contemporary approaches to organ protection,
open abdominal aortic aneurysm (AAA) repair is still as-
sociated with significant morbidity and mortality in
high-risk patients [21]. Multiple organ failure (i.e., the
lung, kidney) and spinal cord injury are related with acti-
vation of inflammatory pathways and over production
of other inflammatory mediators during the thoracoab-
dominal aortic surgery [22,23]. Thoracoabdominal aortic
clamping can lead to systemic inflammatory response and
ischemia occurs as the blood flow through the major ar-
teries supplying blood to remote organs slows down or
stops [24,25].
Among various factors that has been related with end
organ ischemia/reperfusion injury such as distal aorticTable 2 Immunohistochemical results of the kidney tissue
Grade Ischemic control Sham
Number % Number %
MPO 0 0 0 3 60
1 3 37.5 2 40
2 3 37.5 0 0
3 2 25 0 0
HSP70 0 0 0 2 66.7
1 1 12.5 0 0
2 1 12.5 1 33.3
3 6 75 0 0
IL-6 0 3 100 2 40
1 0 0 3 60
2 0 0 0 0hypotension after aortic occlusion, duration of ischemia
and aneurysm extent and microthrombus formation are
most important and avoidable factors [26]. So micro-
thrombus formation associated with blood flow slowing,
stopping and inadequate heparin dose can cause multior-
gan disorders together with histopathological and func-
tional changes [27,28]. Especially, when the hematocrit
level is higher than 40 mg/dl microthrombus may easily
form. It was suggested that microcirculatory disturbances
such as higher blood viscosity characterized by hemocon-
centration and microthrombus formation were associated
with ischemia [29].
Heparin still remains the leading drug in the manage-
ment of anticoagulation. Not only heparin has anti-
coagulant activity but also it has direct anti-inflamatory
action. The role of heparin as an anti-inflamatory and
anticoagulant agent has a wide spectrum of interactions
with various enzymes, hormones, biogenic amines, and
plasma proteins. There is great variability in plasma con-
centration of heparin in relation to dose, so the anti-
coagulant response is not linear. To provide equilibrium
between preventing coagulation and in the mean timeHeparinized High dose-heparinized P value
Number % Number %
3 100 0 0 0.01
0 0 1 33.3
0 0 0 0
0 0 2 66.7
2 40 0 0 0.004
1 20 0 0
2 40 0 0
0 0 3 100
5 62.5 2 66.7 0.205
3 37.5 1 33.3
0 0 0 0
Table 3 Histopathological results of the liver tissue
Grade Ischemic control Sham Heparinized High dose-heparinized P value
Number % Number % Number % Number %
Hepatocyte degeneration 1 1 33.3 0 0 2 28.6 - - 0.085
2 2 66.7 4 66.7 3 42.9 - -
3 0 0 2 33.3 2 28.6 - -
Hepatocyte steatosis 0 2 50 5 100 7 100 - - 0.116
1 2 50 0 0 0 0 - -
Single cell necrosis 0 1 33.3 4 80 2 28.6 - - 0.273
1 1 33.3 1 20 5 71.4 - -
2 1 33.3 0 0 0 0 - -
Inflammatory cell 0 1 33.3 2 40 2 28.6 0 0 0.587
1 2 66.7 3 60 4 57.1 2 66.7
2 0 0 0 0 1 14.3 1 33.3
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has increased the importance of the identification of the
level of anticoagulation. The most popular and predomin-
ant test to monitor anticoagulation is ACT, so we thought
to investigate the effect of ACT levels on end organ ische-
mia in an experimental model.
The presence of patients with postoperative organ dys-
function relationships with response of plasma inflam-
matory mediators after I/Ri. The overexpression and
release of inflammatory mediators, cytokines, activation
of phospholipase A2 and complement system, effects of
adhesion molecules, activation of arachidonic acid sys-
tem make I/R injury very complicated and difficult to
understand [30-32]. Actually, ischemia and reperfusion
is a chain reaction resulting in free oxygen radical gener-
ation, respiratory burst of activated neutrophils that oc-
curs in response to tissue injury and the autooxidation
of cathecolamines [8]. Severin et al. [33] reported thatTable 4 Immunohistochemical results of the liver tissue
Grade Ischemic control Sham
Number % Number %
MPO 0 1 33.3 5 100
1 2 66.7 0 0
2 0 0 0 0
3 0 0 0 0
HSP70 0 0 0 4 80
1 2 28.6 1 20
2 3 42.9 0 0
3 2 28.6 0 0
IL-6 0 1 33.3 0 0
1 2 66.7 4 80
2 0 0 1 20
3 0 0 0 0heparin has anti-inflammatory properties beside its anti-
coagulant effects. This characteristic of heparin has been
attributed to binding certain cytokines, like chemokines
which mediate inflammation through their control of
leukocyte migration and activation. We investigated the
levels of IL-6, MPO and HSP-70 to evaluate the inflam-
matory response to I/R injury and the effect of heparin
on it.
Acute phase proteins, myeloperoxidase and IL-6 are
increase with inflammation [5,34]. HSP-70, a well known
cytoprotective agent increases after I/R and its level is
directly correlated with the degree of tissue injury and
inflammation. In the present study ,the lowest HSP-70
and MPO level in kidney tissue was measured in the
sham group and heparinized groups, showed that the in-
flammation and injury was significantly lower with this
treatment. The decrease in HSP-70 in these groups also
was an indirect proof of lower tissue injury and betterHeparinized High dose-heparinized P value
Number % Number %
3 60 2 66.7 0.152
2 40 1 33.3
0 0 0 0
0 0 0 0
2 66.7 1 33.3 0.053
1 33.3 2 66.7
0 0 0 0
0 0 0 0
6 85.7 2 66.7 0.243
1 14.3 1 33.3
0 0 0 0
0 0 0 0
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ference between the groups in terms of the degree of in-
flammatory response, degree of IL6 kidney tissue.
Cytoplasmic vacuole formation, hemorrhage, tubular
cell degeneration and tubular dilatation in the kidney tis-
sue after I/R were decreased after heparin treatment and
the histopathologic protective effect of heparin was shown
in the present study.
Comparison of immunohistochemical markers and
histopathological evaluation of the ischemia- reperfusion
injury of the liver tissue in an aortic occlusion model of
rats revealed that there was no statistically significant
difference. The reason for this outcome for us that; the
afferent blood supply to the liver arises from two sources:
(i) the hepatic artery, which carries oxygenated blood and
accounts for approximately 25% of hepatic blood flow and
50% of total oxygen, and (ii) the portal vein, which drains
the splanchnic circulation and accounts for approximately
75% of hepatic blood flow. Because of its protection by a
dual blood supply and the capacity for anaerobic metabol-
ism of glycogen stored in the liver, hypoxic damage can
occur later in this organ [35].
The half-life of heparin is approximately 30 minutes,
60 minutes and 150 minutes respectively following IV
bolus of 25 U/kg, 100 U/kg and 400 U/kg [36]. Our clin-
ical routine in abdominal aortic surgery is to administer
bolus of 100 U/kg heparin and to maintain ACT level
around 200 seconds. In the present study there was no
significant difference between heparin groups (ACT: 200
and ACT: 600) in terms of histopathologic changes or
biochemical inflammatory response in the liver and kid-
ney. Also, keeping ACT level around 200 sec during thor-
acoabdominal surgery seems both to ensure the adequate
level of anticoagulation and to avoid the adverse effects
such as bleeding.
Conclusions
Many current analysis clearly evidences that the surgical
repair of TAAA remains a challenge even in this century.
Recent major progress in our understanding of the patho-
physiology and operative strategy have decreased the risk
of open TAAA repair complications but obviously further
investigation is necessary. Heparin is an important anticoa-
gulation agent in thoracoabdominal and abdominal surgical
procedures but no beneficial effects were seen with the use
of higher levels of heparin in the present study. Taking into
account that, bleeding complications will be much less
when heparin used in the real-world clinical practice as
ACT levels of 200. Furthermore, the results of this investi-
gation indicate that heparin molecule has provide to poten-
tial anti-inflammatory property and renal protective action.
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